Summary & Overview
HCPCS A2015: Phoenix Wound Matrix, Per Square Centimeter
HCPCS Level II code A2015 identifies the Phoenix wound matrix, billed per square centimeter as an add-on supply used alongside a primary wound-care procedure. The code captures use of an advanced biologic or matrix material intended to support tissue regeneration in acute and chronic wounds. Nationally, accurate reporting of add-on supply codes like A2015 matters for tracking utilization of advanced wound products, managing supply costs, and ensuring clarity between procedural and supply reimbursement.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for the product, typical sites of service (outpatient wound clinics, ambulatory surgery centers, and hospital outpatient departments), and the role of the code as an add-on, list separately line item. The publication also outlines common modifiers used with add-on supply billing and notes where input data is not available for certain fields.
The piece provides benchmarks and operational considerations relevant to billing teams and revenue cycle managers, highlights coding and billing nuances for add-on supplies, and summarizes policy considerations affecting coverage and documentation requirements. Data not available in the input is clearly identified so readers can prioritize areas for local validation and payer-specific policy review.
Billing Code Overview
HCPCS Level II code A2015 describes the Phoenix wound matrix, billed per square centimeter. This entry is an add-on, list separately in addition to primary procedure supply used in wound care to support tissue regeneration in acute or chronic wounds.
-
Service type: Advanced wound care supply applied as part of a procedure or treatment session
-
Typical site of service: Outpatient wound care clinics, ambulatory surgery centers, hospital outpatient departments, and other settings where advanced wound products are applied
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a chronic, non-healing lower extremity or pressure wound (for example, a diabetic foot ulcer or stage IV pressure ulcer) who has failed initial conservative care such as debridement, infection control, offloading, and advanced dressings. The wound care clinician (podiatrist, wound care surgeon, or plastic surgeon) evaluates the wound in an outpatient wound clinic or ambulatory surgery center. After appropriate wound bed preparation — including sharp or enzymatic debridement, infection management, and optimization of perfusion — the clinician decides to apply a biologic wound scaffold product, billed with A2015 per square centimeter as an add-on to the primary procedure. The service is typically provided in the outpatient clinic or ambulatory surgery center; application may occur under local anesthesia with or without light sedation. Documentation includes wound measurements (length, width, depth and calculated square centimeters), indication for use of the product, sterile technique, description of any debridement or adjunctive procedures performed, and the number of square centimeters of matrix applied. The clinical workflow often includes wound measurement and photography pre-application, informed consent, preparation of the wound bed, application of the wound matrix, securement with appropriate dressings, and post-application instructions with a follow-up plan for reassessment and additional applications if needed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |